Implementation and Evaluation of a Pediatric Behavioral Health Medication Reconciliation Program in a Regional

Taylor Norris1, Robert Davis1, Steve Willis1

  • 1Department of Pharmacy (TN, RD, SW, MW, AD, KN, PHL) and Department of Nursing (SJ), Brown University Health Hasbro Children's, Providence, RI.

Insights

A pharmacy-managed medication reconciliation program for pediatric behavioral health patients increased medication discrepancies identified. However, the time to complete medication reconciliation also significantly increased after program implementation.

Area of Science:

  • Pediatric Emergency Medicine
  • Behavioral Health Pharmacy Services
  • Medication Reconciliation

Background:

  • Limited data exists on pharmacy-led medication reconciliation for pediatric behavioral health patients.
  • Inpatient admissions for pediatric behavioral health often originate from emergency departments.

Purpose of the Study:

  • To evaluate the impact of a pharmacy-managed medication reconciliation program.
  • Focus on pediatric behavioral health patients admitted via a pediatric emergency department.

Main Methods:

  • Retrospective, single-center, pre-post design study.
  • Compared medication reconciliation interventions and completion times before and after program implementation.
  • Data collected over two 2-month periods.

Main Results:

  • Significantly higher number of pharmacist interventions post-implementation (129 vs 61).
  • Medication discontinuation was the most common intervention.
  • Average time to complete reconciliation increased from 16.33 to 38.47 hours.

Conclusions:

  • Pharmacy programs can enhance identification of medication discrepancies in this population.
  • Increased time to reconciliation completion was observed post-implementation.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
277
Interdisciplinary Care: The Health Care Team-I01:21

Interdisciplinary Care: The Health Care Team-I

An interdisciplinary team includes many healthcare professionals working together and utilizing their skills, knowledge, and expertise to provide holistic and quality patient care.
Physicians
The physician's primary responsibility is to diagnose illness and direct the medical or surgical treatment of the condition. The authority to admit patients to a healthcare agency or institution and practice care within that setting is granted to physicians by the healthcare agency or institution...
2.8K
Interdisciplinary Care: The Health Care Team-II01:18

Interdisciplinary Care: The Health Care Team-II

An interdisciplinary team includes many healthcare professionals working together and utilizing their skills, knowledge, and expertise to provide holistic and quality patient care. Here are a few more healthcare professionals.
Physical Therapist
A physical therapist (PT) aims to restore function or prevent additional impairment in a patient following an injury or disease. Massage, heat, cold, water, sonar waves, exercises, and electrical stimulation are some treatments used by PTs to treat...
2.3K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
334
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
246
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
310